Predicting vaginal invasion in cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial aims to create a tool to predict if cervical cancer has spread to the vagina. It uses MRI scans and blood tests to help doctors decide the best treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cervical cancer through a biopsy
- Your cancer is at stage IB to IIA (early stages that haven't spread far)
- You have not had any treatment for your cancer before surgery
- You had an MRI of your belly within 3 weeks before surgery
- You had blood tests within 1 week before surgery
- You are scheduled for a radical hysterectomy with lymph node removal
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans taken before treatment to predict survival in women getting radiation therapy for cervical cancer. It helps doctors understand which patients may do better and guide future care.
This trial studies whether a special MRI scan can better predict whether early cervical cancer has spread into tiny lymph and blood vessels (lymphovascular space invasion) before surgery. If it works, it may help doctors plan the best treatment after surgery.
This study uses artificial intelligence to analyze your preoperative MRI and pathology results to better predict if cervical cancer has spread to pelvic lymph nodes. The goal is to improve future treatment decisions for patients with cervical cancer.
This trial uses MRI scans taken before treatment to see if they can predict how well chemo-radiation will work for locally advanced cervical cancer. It aims to help doctors know which patients might benefit most from this therapy.
This study compares an AI prediction model to standard MRI imaging to see which better identifies if cervical cancer has spread to lymph nodes. It aims to improve accuracy and help guide treatment decisions for women with early- to mid-stage cervical cancer.
This trial combines radiation, chemotherapy, and internal radiation therapy to treat vaginal cancer. It aims to see if this approach is safe and effective for patients with different stages of the disease.
Hear when a new Cervix Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.